Table 3: Demographic data and baseline characteristics: intent-to-treat analysis.

Group A (n = 114)Group B (n = 117)Group C (n = 115) P values

Sex ratio (male/female)71/4376/4175/400.2630.877
Age (years) (mean ± SD)35.98 ± 12.45336.12 ± 12.46535.64 ± 12.1350.0460.955
Body weight (kg) (mean ± SD)61.12 ± 10.51460.23 ± 8.85558.98 ± 9.8271.3870.251
Height (cm) (mean ± SD)164.63 ± 8.223164.36 ± 7.750164.11 ± 8.2660.1180.889
Body temperature (°C) (mean ± SD)36.95 ± 0.45136.90 ± 0.48136.98 ± 0.5070.8550.426
Course (hours) (mean ± SD)22.75 ± 11.09624.21 ± 12.10423.42 ± 11.4770.5160.772
Main symptoms score (mean ± SD)
 Avertion to cold4.68 ± 1.7414.59 ± 1.6984.85 ± 1.7131.4770.478
 Nasal discharge5.58 ± 1.9915.26 ± 1.8445.69 ± 2.0022.8360.242
Minor symptoms score (mean ± SD)0.478
 Arthralgia of extremities1.33 ± 0.8161.26 ± 0.7701.28 ± 0.7790.2980.861
 Fever0.45 ± 0.7050.40 ± 0.7320.49 ± 0.7881.0800.583
 Headache1.01 ± 0.7351.04 ± 0.7810.97 ± 0.7250.4920.782
 Stuffy nose1.66 ± 0.7621.47 ± 0.6771.64 ± 0.7524.0820.130
 Sneezing1.38 ± 0.8031.52 ± 0.6901.42 ± 0.8272.3380.311
 Spiritlessness and weakness1.18 ± 0.7711.25 ± 0.6841.29 ± 0.7581.1020.576
Cumulative symptoms score (mean ± SD)17.27 ± 4.70016.79 ± 4.33317.63 ± 4.9790.9620.383

Chi-square test.
One-way analysis of variance.
Kruskal-Wallis H test.